Marksans Pharma - Quarterly Results
13th Feb 2023
The company's total revenue for the quarter ended December 2022 saw a slight change in the total revenue, having registered a total revenue of Rs. 1727.48 millions.A slender decline of -1.67% was recorded to Rs. 256.22 millions from Rs. 260.57 millions in the corresponding previous quarter.A decline of 395.30 millions was observed in the OP in the quarter ended December 2022 from 398.85 millions on QoQ basis.
| | Quarter ended | Year to Date | Year ended |
| | 202212 | 202112 | % Var | 202212 | 202112 | % Var | 202203 | 202103 | % Var |
| Sales | 1727.48 | 1659.37 | 4.10 | 5021.59 | 4820.11 | 4.18 | 6582.89 | 5995.48 | 9.80 |
| Other Income | 157.14 | 120.65 | 30.24 | 561.80 | 346.03 | 62.36 | 422.51 | 311.56 | 35.61 |
| PBIDT | 395.30 | 398.85 | -0.89 | 1253.74 | 1214.49 | 3.23 | 1559.66 | 1448.68 | 7.66 |
| Interest | 8.48 | 6.85 | 23.80 | 29.56 | 25.17 | 17.44 | 37.95 | 53.45 | -29.00 |
| PBDT | 386.82 | 392.00 | -1.32 | 1224.18 | 1189.32 | 2.93 | 1521.71 | 1395.23 | 9.07 |
| Depreciation | 41.79 | 45.21 | -7.56 | 132.27 | 130.54 | 1.33 | 176.63 | 151.93 | 16.26 |
| PBT | 345.03 | 346.79 | -0.51 | 1091.91 | 1058.78 | 3.13 | 1345.08 | 1243.30 | 8.19 |
| TAX | 88.81 | 86.22 | 3.00 | 241.34 | 233.18 | 3.50 | 305.20 | 259.49 | 17.62 |
| Deferred Tax | 1.56 | 1.22 | 27.87 | 2.50 | 16.30 | -84.66 | 5.04 | -22.39 | -122.51 |
| PAT | 256.22 | 260.57 | -1.67 | 850.57 | 825.60 | 3.02 | 1039.88 | 983.81 | 5.70 |
| Equity | 402.96 | 409.31 | -1.55 | 409.31 | 409.31 | 0.00 | 409.31 | 409.31 | 0.00 |
| PBIDTM(%) | 22.88 | 24.04 | -4.80 | 24.97 | 25.20 | -0.91 | 23.69 | 24.16 | -1.95 |